Patent US4831018A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4831018A Expired / Lapsed US ⏱️ 0.0 years remaining

Polyene antibiotic emulsion formulation

Assignee: SmithKline Beecham Corp
•
Filing: 1987-03-25
•
Granted: 1989-05-16
•
Expires: 2007-03-25
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A polyene antibiotic emulsion formulation comprising a therapeutically effective amount of the antibiotic incorporated into an oil-in-water emulsion, and a method of treating an active infection in an animal caused by a microorganism with sterols in its cell membrane by parenterally administering the emulsion formulation to such animal.

Inventors

  • 👤 Richard L. Kirsh
  • 👤 Louis J. Ravin

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 10:54
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/70; A61K9/00; A61K9/10; A61K9/107; A61K9/1075; C; C07; C07H; C07H17/00; C07H17/04; C07H17/08

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 52 words
A package comprising a container of a pharmaceutical formulation suitable for admixture to a parenterally administerable oil-in-water emulsion which formulation includes amphotericin B and dimethylacetamide in an amount sufficient to incorporate the amphotericin B into the oil-in-water emulsion upon admixture, and a second container of an oil-in-water emulsion suitable for parenteral administration.
Claim 2
Dependent Claim 52 words
A package comprising a container of a pharmaceutical formulation suitable for admixture to a parenterally administerable oil-in-water emulsion which formulation includes amphotericin B and dimethylacetamide in an amount sufficient to incorporate the amphotericin B into the oil-in-water emulsion upon admixture, and a second container of an oil-in-water emulsion suitable for parenteral administration.
Claim 3
Dependent Claim 37 words
A package of claim 2 wherein the container of the pharmaceutical formulation of amphotericin B and dimethylacetamide includes deoxycholic acid in an amount sufficient to facilitate incorporation of the amphotericin B into the oil-in-water emulsion upon admixture.
Claim 4
Dependent Claim 47 words
A package comprising a container of amphotericin B suitable for parenteral administration, a second container of dimethylacetamide suitable for parenteral administration in an amount sufficient to incorporate amphotericin B into an oil-in-water emulsion upon admixture, and a third container of an oil-in-water emulsion suitable for parenteral administration.
Claim 5
Dependent Claim 47 words
A package comprising a container of amphotericin B suitable for parenteral administration, a second container of dimethylacetamide suitable for parenteral administration in an amount sufficient to incorporate amphotericin B into an oil-in-water emulsion upon admixture, and a third container of an oil-in-water emulsion suitable for parenteral administration.
Claim 6
Dependent Claim 29 words
A package of claim 3 wherein the second container of dimethylacetaide includes deoxycholic acid in an amount sufficient to facilitate incorporation of the amphotericin B into the oil-in-water emulsion.

References Cited (Backward Citations)

US4158707A Cited
US4432756A Cited
US4493702A Cited
US4432754A Cited
US4573974A Cited
US4707470A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-05-15 1992-11-14 1993-05-16 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-05-15 1996-11-14 1997-05-16 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-05-15 2000-11-14 2001-05-16 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag